Ferte Health Capsule
Natural health product licensed in Canada
- Licence holder
- NuEra Nutraceutical Inc.
- NPN or DIN-HM
- 80079501
- Status
- Active licence
- Licence date
- 17 August 2017
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Zinc: up to 33 mg a day according to the dosing instructions published by Health Canada (3 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 15 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Zinc: up to 33 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (25 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Tribulus terrestris L.: Les parties de plantes doivent être cuites
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Lepidium meyenii Source : Lepidium meyenii - racine Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 milligramme | 100 milligramme | Not calculated |
| Tribulus terrestris Source : Tribulus terrestris - Fruit Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 150 milligramme Potency : 40 % Steroidal Saponins | 15 milligramme | Not calculated |
| 2,5-Cyclohexadiène-1,4-dione, 2-[(2E,6E,10E,14E,18E,22E,26E,30E,34E)-3,7,11,15,19,23,27,31,35,39-décaméthyl-2,6,10,14,18,22,26,30,34,38-tétracontadécaényl]-5,6-diméthoxy-3-méthyl Source : Coenzyme Q10 | 100 milligramme | Not calculated |
| Zinc Source : Oxyde de zinc | 11 milligramme | 33,000 µg |
| Sélénium Source : Levure enrichie de sélénium | 55 microgrammes | Not calculated |
| Vitamine C Source : Acide ascorbique | 50 milligramme | 150,000 µg |
| L-arginine Source : L-arginine | 80 milligramme | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 6.9 mg AT | Not calculated |
| Pinus pinaster Source : Écorce (tige) Extract : Matériel brut sec Extraction ratio : 10:1 Dry plant equivalent : 1,000 milligramme Potency : 90 % Procyanidins | 100 milligramme | Not calculated |
| Vitamine E Source : Acétate de dl-alpha tocophéryle | 15 UI | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Stéarate de magnésium, Eau purifiée, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Capsule | 3 days |
Uses authorised in Canada
Provides antioxidants. Helps to support emotional aspects of sexual health. Helps to maintain and/or support cardiovascular health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use.
- Précautions et mises en garde
If you are pregnant of breastfeeding, consult a health care practitioner prior to use. If you are taking antidepressants and/or blood thinners consult a health care practitioner prior to use. If you have high blood pressure, consult a health care practitioner prior to use. If you suffer from any psychological disorder and/or condition such as frequent anxiety or depression, consult a healthcare practitioner prior to use. Consult a health care practitioner prior to use if you are taking blood pressure medication.
Source
Official Health Canada record, licence 80079501
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.